This Week's NCI Cancer Bulletin: Mar 4 2008

-----BEGIN PGP SIGNED MESSAGE-----

This Week's NCI Cancer Bulletin:
* w w w .cancer.gov/ncicancerbulletin/NCI_Cancer_Bulletin_030408

Featured Article
ALTTO Trial Seeks to Define Best Therapy for HER2 Breast Cancer

Cancer Research Highlights
Cancer Risk Persists After Ending Hormone Therapy

Hormone Therapy Interferes with Breast Cancer Detection

Study Confirms Clot, Mortality Risks with Anemia Drugs

Sentinel Node Dissection Safe in Early Vulvar Cancer Treatment

Smoking Threatens Pregnant Women in Developing Countries

Director's Update
Keeping Recent Mortality Figures in Perspective
Funding Opportunities

Special Report
Tiny Nodules, Big Dilemma

FDA Update
Bevacizumab Approved for Metastatic Breast Cancer

Featured Clinical Trial
Continuing Bevacizumab Therapy for Metastatic Colorectal Cancer

Notes
NIH Director to Testify Before Appropriations Subcommittee

BSA Meeting Held

Special Issue on Childhood Cancers

Cancer Center Profile
Lombardi Comprehensive Cancer Center




=================================

Do you know someone who would enjoy receiving the NCI Cancer
Bulletin? To send a copy of the latest issue to a colleague, visit
w w w .cancer.gov/ncicancerbulletin.The NCI Cancer Bulletin will be sent
to you each week unless you ask to unsubscribe.


=================================

E.

-----BEGIN PGP SIGNATURE-----
Version: PGP Personal Privacy 6.5.3

iQEVAwUBR84ITtAqdZr/mrO9AQH7xQf/SzpVOCzIhNYIaAI3gIBjb8XN9FgwsIQx
FgNFsxa9ZuvAvlhKaawq5zMjTmlhkZwu0NztOMAAxK8SCwbMYpFKvedZkACuxvmf
FMAmUkVx80BSdmWSCV4z0qBvBeHKphNMdhOx7OiMrEQPf/erxxUme+4AxGAZQ3iM
Gkj8kcqNBuJUwVr7Jt0zZyZNjMB9sIhf6wcKDmu34xzRnoI1KfE6cra123yDkZme
KIHSps9XSF72p+7QgCgGyPDSwPi2Sj6zqWGORW/V3GpgtiPwsKX89M80UZhfAWNC
fFh3Wa7rlzYhZkG0Gya2OoJZjwIxUw3HPW1vPTA9H24QYiAslXLO1A==
=eiL/
-----END PGP SIGNATURE-----